First gene therapy to treat rare disease Wiskott-Aldrich syndrome
Submitted by Anonymous (not verified) on 14 November 2025 - 11:00
First gene therapy to treat rare disease Wiskott-Aldrich syndrome
Human medicines European public assessment report (EPAR): Juluca, dolutegravir,rilpivirine, Date of authorisation: 16/05/2018, Revision: 16, Status: Authorised
Submitted by Anonymous (not verified) on 14 November 2025 - 10:33
Human medicines European public assessment report (EPAR): Juluca, dolutegravir,rilpivirine, Date of authorisation: 16/05/2018, Revision: 16, Status: Authorised
European Medicines Agency and Transcelerate bilateral meeting, Online, European Medicines Agency, Amsterdam, the Netherlands, 17 November 2025
Submitted by Anonymous (not verified) on 14 November 2025 - 10:24
European Medicines Agency and Transcelerate bilateral meeting, Online, European Medicines Agency, Amsterdam, the Netherlands, 17 November 2025
Human medicines European public assessment report (EPAR): Tivicay, dolutegravir, Date of authorisation: 16/01/2014, Revision: 37, Status: Authorised
Submitted by Anonymous (not verified) on 14 November 2025 - 9:46
Human medicines European public assessment report (EPAR): Tivicay, dolutegravir, Date of authorisation: 16/01/2014, Revision: 37, Status: Authorised
Bronchitol
Submitted by Anonymous (not verified) on 14 November 2025 - 9:38
Bronchitol
Medicine shortage communication (MSC) : Bronchitol, 40 mg inhalation powder, hard capsules: ongoing shortage
Submitted by Anonymous (not verified) on 14 November 2025 - 9:37
Medicine shortage communication (MSC) : Bronchitol, 40 mg inhalation powder, hard capsules: ongoing shortage
Human medicines European public assessment report (EPAR): Zavicefta, ceftazidime,avibactam, Date of authorisation: 23/06/2016, Revision: 20, Status: Authorised
Submitted by Anonymous (not verified) on 14 November 2025 - 9:10
Human medicines European public assessment report (EPAR): Zavicefta, ceftazidime,avibactam, Date of authorisation: 23/06/2016, Revision: 20, Status: Authorised
Minutes of the CVMP meeting 7-9 October 2025
Submitted by Anonymous (not verified) on 14 November 2025 - 9:09
Minutes of the CVMP meeting 7-9 October 2025
Assessment of the risk to public health from antimicrobial resistance due to the use of an antimicrobial veterinary medicinal product in non-food-producing animal species - Scientific guideline
Submitted by Anonymous (not verified) on 14 November 2025 - 8:48
Assessment of the risk to public health from antimicrobial resistance due to the use of an antimicrobial veterinary medicinal product in non-food-producing animal species - Scientific guideline
Concept paper for the development of a guideline on the assessment of the risk to public health from antimicrobial resistance due to the use of an antimicrobial veterinary medicinal product in non-food-producing animal species
Submitted by Anonymous (not verified) on 14 November 2025 - 8:48
Concept paper for the development of a guideline on the assessment of the risk to public health from antimicrobial resistance due to the use of an antimicrobial veterinary medicinal product in non-food-producing animal species